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cares. 
Approxinmtcly half of all deaths in advanced heart failure 
occur suddenly and unexpectedly (1.2). Cardiac arrhythmias 
are an important cause ofsuddcn death in heart failure, but the 
mechanisms triggering the fatal event are largely unknown (2). 
An important clue to triggering mechanisms may be the time 
of day at which the cardiac arrest occurs. In the gcncrul 
population, in whom coronary artcry athcrosclcrosis is the 
predominant cause of heart disease, the incidence of sudden 
death peaks in the morning hours between h AM and I2 noon 
(3,4). It has been suggested that the morning surge in sympa- 
thetic nervous system activity may trigger ischemia and ar- 
rhythmias (4). This hypothesis is consistent with the morning 
peak in the incidence of acute myocardial infarction (5-g). 
Whether there is a morning increase in the incidence of sudden 
death in patients with heart failure is unknown. 
Several factors could influence the timing of sudden death 
in patients with heart failure. Sudden death occurs by II variety 
of mechanisms whose incidence in these patients may differ 
from that in other patient groups (9). In patients with heart 
failure, periodic breathing with episodes of central apnea or 
hypopnca (Cheync-Stokes respiration) and episodes of severe 
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bypoxemia are common during sleep (10) and could theoreti- 
cally increase the incidence of nocturnal arrhythmias and 
sudden death. The etiology of heart failure may also be 
important. Patients with heart failure in the absence of coro- 
nary artery disease would presumably be at low risk for 
coronary thrombosis and this cause of ischomic arrhythmias. 
The purpose of this study was to determine whether sudden 
death in patients with advanced heart failure exhibits the 
morning increase previously described in the general popula- 
tion (3.4). 
Patients. We identified all patients who had a sudden 
death from among the 566 consecutive patients followed up in 
the Ahmansen-UCLA Cardiomyopathy Center after in- 
hospital treatment for advanced heart failure from January 
1085 to January 1992. Patients were referred to the clinic for 
evaluation for heart transplantation or optimization of medical 
therapy, or both. Eighty percent of the patients were male; the 
mean age 2 SD was 50 + 13 years. Patients had symptoms of 
heart failure at rest or with slight exertion (New York Heart 
Association functional class III or 1V) at the time of referral. 
Mean left ventricular ejection fraction on referral was 20 + 
8%. Etiology of heart failure was determined from the pa- 
tient’s history and from coronary artcriography. Coronary 
artery disease was defined as stenosis >50% in any coronary 
artery. Heart failure was due to coronary artery disease in 48% 
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Table 1. Clinical Characteristics of Study Patients Compared hy Status 
Hc;lrI 
AliVC !hdden Death Other Delllh Transplantatic~n 
Patients 126 (22.3% ) YS {l73i) I12 (1Y.K;) I’JS (3d.‘Jp; ) 
Age Cvr) 51 z 12 -1x: 13 51 2 15 51 + ll 
LVEF (%)” 2.3 + x 1’) 2 h !I1 z R 21 +I) 
NYHA functional cliis* 3.4 z 0.7 3.5 2 0.7 2.6 ? (I.5 3.5 ?: 0th 
%iUlIl sodium (mmollliter)” KM+4 I.36 2 5 I33 6 5 1% 2 3 
Initial RAP (mm Hg)’ II 28 IZ 2 x I4 2 8 II 27 
Initial PCWP (mm Hg)” 222 II 27 + 0 2-7 10 25 ?I 10 
Initial Cl (liters/min per m2)* 2.1 c 0.7 2.1 I 0.7 2.0 L 0.7 2.1 t 0.Y 
Finn1 RAP (mm t(g)? 7*d 724 0 + .s b + d 
Finitl PCWP (mm IQ)? 14 z.5 17 + 6 17 ” 0 65 .! 5 
Final C’I (litrrslmin per nr”)f 2.0 ” Mb 1.7 : 1.7 ‘.h ! 11.7 ’ i : u.5 _.. 
Men w(7Y’;) XI (w ) ‘!I (815) lb! (52“; 
ClnD4F 43 (34% ) 42 (43’; ) 2 (w; ) I Iv(tlII’; 
Nankhcmic HI: x3 ((lb”; ) 50 (57’; ) hll(.il’; ) 70 (Wi 
ACE18 73 (wi ) 3O(Wi ) 44 (w;) IM(Wi 
ilytlr;rl;tzinc$ ?Y(.3’;) JY (51)‘; ) 5.? (47’; ) 0.2 (X’, 
t ly~lrirlurinc + A(‘til$ 0 (5”; ) 3 (35 ) !(I!‘,) I!(I’;) 
Antiarrhythmk ~~RrnI*$ 13(58’; ) 52 (53’; ) .H(.w;) 105 (5.3~; ) 
Digiti&* 7d (5’J’; ) R(6ll’;) 45 iw; ) 
i ;hb , ) 
I IO (.%I’,) 
Nitratcs$ Yd (5Y5) 71 (72’;) 112(7”r) 
*C’huru&ristks ilt initkl mhtion Mm qtiniiratian cd undid thcr;lpy. ?tlcmcwlgn;mk (lilI;l ;Iitcr optimizulion 
of mcdiwl thcnpy. *Drug thwpy at dischqc. Data prcscntcd xc’ mC’U ~luc .! SD or numlwr (‘; ) cd p;knIs. 
ACEI = itnbiotL’nsin.n,llvcrtin~ cnzzmr: inhibitor thcrqyy: CAD-l~llz 2. hc;lrt fxilurr due IO c~~r~ul;uy xtrq ~liww: (‘I 
cmliac index; tIF - hc;trt failure: LVEF = Ich vcnkulnr cjretion frxtion: NYtM = Ncu York tlC;lrI Awci;~licw 
PCWP = pulmun;lry cupillary WC@! prcssurc: RAP T= right ;Ilrinl pwwrs. 
of patients and to nonischcmic disease in the remaining 52’ii 
(idiopathic dilated cardiomyopathy in 44%. valvular heart 
disease in 6%. other in 2%). 
Determination of sudden death. Patient deaths wcrc pro- 
spcctivcly categorized as sudden death. death due to heart 
failure or noncardiac death. Sudden death was delined as an 
unexpected cardiac arrest that occurred outside the hospital 
within IS min of a change in symptoms or during sleep in a 
previously amhulatoty patient in stable condition. Any death 
occurring in the context of dccompcnsatcd heart failure was 
excluded from the definition of sudden death. Deaths were 
categorized after conferring with the patients’ physicians and 
with family mcmhers who were with the patient at the time of 
death, Time of death was determined retrospectively from 
witnesses to the event and from the death certificate. If an 
unsucvcssful resuscitation attempt followed the sudden death 
event, the time of death was determined to be the time the 
cardiac arrest occurred. 
Data analysis. Clinical characteristics of patient subgroups 
(alive at follow-up. sudden death, other death and heart 
transplantation) wet-c compared by using chi-square analysis 
for nominal or categoric level data and analysis of variance for 
interval level data. A Bonferroni adjustment was used to 
correct the alpha level for multiple post hoc comparisons of 
characteristics. Frequency of sudden deaths was determined 
for every hour of the day beginning 1 min after the preceding 
hour (e.g., 12~01 AM to 1 AM). In addition, frequencies were 
tabulated for the following 6-h intervals: 6~01 AM to 12 noon, 
I?:01 PM to 6 i’hl. 6:Ol I’M to 12 midnight and 12:OI ,IM to 6 AM. 
The incidence of sudden death in 6-h intervals for the cntirc 
grorip, and then for patients with heart failure due to coronary 
artery disease and for patients with heart failure due to 
nonischcmic causes was compared and tested for uniformity by 
using chi-square tests For goodness of tit. When significant 
diffcrenccs wore found. the interval with the largest number of 
sudden deaths was tcstcd to determine the dificrencc from the 
remaining three mtervals. To determine the excess incidence 
of sudden death. tho ratio between the pcrccnt of sudden 
deaths in the interval with the highest frcqucncy of such deaths 
and the average pcrccnt of such deaths for the other three 
intervals was computed. The independcncc of time of day of 
sudden death for patients with heart failure duo to cor(~~ail~ 
artery disease versus patients with heart failure due to nonisch- 
cmic Causes was examined by using the chi-syuarc test from a 
2 X 4 continccncy tilhk. Significance was set at p < 0.05. _ 
esdts 
Of 566 patients, 210 (37%) died during a mean follow-up 
period of 18.3 months, 198 (33%) reccivcd a heart transplant 
and 32 (6%) were lost to follow-up. There were 98 sudden 
deaths (17.3%), 100 deaths due to heart failure (17.7%) and 12 
deaths from noncardiac causes (2.1%). Clinical characteristics 
among the patient subgroups are compared in Table 1. There 
were no differences among the patient subgroups based on age 
(p = 0.2), gender (p = 0.9), New York Heart Association 
number of sudden deaths 
classifcalion (p = O.S), initial (at WillU~ltiOlI bcforc optimiza- 
tion of medical therapy) right atrial prcssurc (p = 0.07) I)I 
initial or final (after CVillUittil~~~ 3nd optimization of lncdical 
thcriifly) Glrdiilc iHdcS (13 - 0.S flN IWtll). ‘lkl-C WCI’C tlVlldS 
for dilfcrcnccs among groups based on nitrate therapy (p = 
Mh). digitalis therapy (p = 0.05) and antiarrhythmic drug 
therllpy (p = O.OS), but thcsc comparisons did not reach 
statistical signiticancc. 
Thcrc were group dilfcrcnccs based on etiology of heart 
disease (p = 0.007). vasodilator therapy (p = O.(1OS). left 
ventricular ejection fractiun (p = 0.03), sodium level at initial 
evaluation (p < O.OOS), finill right atrial prcssurc (p = 0.0003) 
and initial and final pulmonary capillary wedge pressure (p = 
0.002). Post hoc comparisons revealed that differences among 
the groups in vasodilator therapy were accounted for by 
the fact that the proportion of patients who were receiving 
angiotcnsin-converting enzyme inhibiting agents was greater 
among those who were alive at follow-up than among those 
who died suddenly or from progressive heart failure. Patients 
who died suddenly had a lower ejection fraction than that of 
patients in the other groups. Serum sodium was lower in 
patients who died from heart failure than in patients in the 
other groups, whereas hot initial and final pulmonary capil- 
lary wedge pressures were higher in patients who died suddenly 
or of progressive heart failure than in those who were alive at 
follow-up. Final right atrial pressure was higher in patients who 
died from progressive heart failure than in lhc other three 
patient groups. 
Qf the 98 sudden deaths, time of death could be determined 
for 72. Clinical characteristics were not statistically different 
between patients with a known as compared to an unknown 
time of sudden death. 
Examination of the frcyucncy distribution of time of sud- 
den death for all 72 patients with a known time of death 
rcvcaled a morning peak in incidcncc (Fig. I ). The frequency 
of sudden death was much greater between the hours of h:OI 
AM and I? noon than in the other O-h intervals, with 46% of 
deaths occurring during this time period (p < 0.005). Fourteen 
percent of the deaths occurred bctwecn 12:Ol AM and h AM, 
23% from 12:Ol WI to 6 I’M and IW from (,:()I I’M to 12 
midnight. Sudden death occurred 2.5 times more frequently 
bctwccn Ml1 AM and I.? noon than during the other three 
intervals. Analysis of patient subgroups revealed a signihcarrt 
morning peak in incidence of sudden death both in patients 
with coronary artery disease (p < 0.05) and in patients with 
nonischemic causes of heart failure (p < 0.005). There were no 
differences in the frequency distribution of sudden death for 
patients with heart failure due to coronary artery disease and 
that for patients with nonischemic causes of heart failure (p - 
0.69) (Fig. 2). 
§SiQk!I 
Patients with cardiovascular and cerebrovascular disease 
exhibit a morning increase in the incidence of acute myocardial 
infarction (5-X), transient myocardial ischemia (11). slrokc 
(12-14) and sustained ventricular tachycardia (15). In the 
generai population there iS a Similar IIIOrnitig iivx!xX is the 
incidence of sudden death ($4). The timing of sudden death in 
patients with advanced heart failure has not been described 
previously. This study demonstratcs that in these patients the 
risk of dying suddenly is greater in the hours from 6 AM to 12 
noon than at any other time period. Patients with both 
ischemic and nonischemic causes of heart failure exhibit this 
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Figure 2. Frcqucmy distribution in 6-h intcr- 
viils uf time of sudden dNh for pticnt~ with 
heart failure (HF) due 10 either cornnary artcty 
discilsc (CAD) or nonischcmic CiIusCS (NOW 
CAD). 
NWl-12plll 12pm-6pm 
tlmo of day in B-hour epoch6 
Bpm-1 Pam 
morning increase in incidence of sudden death. Our classitica- 
tion of patient deaths is supported by the differcncc: in 
ejection fraction, initial sodium level, final right atrial pressure. 
pulmonary capillary wedge pressure and vasodilator USC that 
we observed among patients identified as having died suddenly 
and thase identified as alive, as having had a heart transplant 
or having died of other causes (primarily progressive heart 
failure). 
Despite a high incidence of sleep abnormalities that could 
contribute to nocturnal arrhythmias (10) in patients with 
advanced heart failure the incidence of sudden death is not 
higher during the night hours in this group. The high incidence 
of sudden death during the morning hours implicates the 
sympathetic nervous system surge that occurs on arising after 
sleep as a possible trigger of sudden death. Sympathetic 
nervous system activity exhibits a circadian rhythm character- 
ized by diminished activity in the late night hours before 
awakening and a peak in the morning hours associated with 
assumption of the upright position on awakening (16-20). The 
morning increase in cardiovascular events is related to the time 
of awakening and not simply to the time of day, providing 
support for the hypothesis that the morning surge in sympa- 
thetic activity can precipitate acute cardiovascular events 
(8,11,14). Evidcecc that heart rate variability in survivors of 
cardiac arrest exhibits a circadian rhythm such that heart rate 
variability is lowest in the morning is also consistent with this 
view (21). Beta-adrenergic blocking agents abolish the morn- 
ing increase in myocardial infarction or sudden death (5-7). 
Sudden death in heart failure can be caused by a variety of 
mechanisms including acute myocardial infarction, thrombo- 
embolic events and arrhythmias (9). Susceptibility to all of 
these conditions can he incrcascd by activation d the sympa- 
thctic nervous system. 
In patients with coronary artery disease, sympathetic acti- 
vation increases vascular sheer forces secondary to clcvation of 
blood prcssurc. heart rate and rate of prcssurc change (dP/dt). 
Myocardial oxygen demand is increased, coronary artery vaso- 
constriction produced and platelet aggregability enhanced 
without an adequate counteracting increase in tibrinolytic 
activity (17,18,22). Together these forces can trigger rupture of 
a vulnerable atherosclerotic plaque and acute myocardial 
infarction (20). The hypcrcoagulable state produced by sym- 
pathetic activation can also promote acute thromboembolic 
events. Sympathetic activity increases susceptibility to ventric- 
ular tachyarrhythmias during ischemia and in the presence of 
electrolyte abnormalities (particularly potassium and magne- 
sium deficits common in patients with heart failure) (23-25). 
In patients with heart failure without coronary artery dis- 
case, the mechanisms of arrhythmias arc not well defined, but 
high sympathetic tone is likely a promoting factor. Sympathetic 
stimulation increases cytosolic calcium and can promote after- 
depolarizations and triggered activity (26). Malignant vagal 
discharges may be more likely to occur when sympathetic tone 
is high, causing severe bradyarrhythmias (9,27). 
Limitations of the study. A limitation of this study is failure 
to adjust time of sudden death to time of awakening. Such 
information is extremely difficult to obtain accurately from 
other informants. However, on the basis of previous studies 
(S), it is likely that adjustment of time of sudden death to time 
of awakening would serge to strengthen the pattern of a 
morning increase in incidence of sudden death. Despite the 
variety of potential sudden death mechanisms and heart failure 
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similar 24-h distribution 
patients, implicating increased syrn~~~~~~~jc nerves system 
activation. 
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